Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature.
about
Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review.Recent Advances in Prostate Cancer Treatment and Drug Discovery.Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen.
P2860
Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Efficacy and safety of post-do ...... atic review of the literature.
@en
type
label
Efficacy and safety of post-do ...... atic review of the literature.
@en
prefLabel
Efficacy and safety of post-do ...... atic review of the literature.
@en
P2093
P2860
P1476
Efficacy and safety of post-do ...... atic review of the literature.
@en
P2093
Jacqueline Vanderpuye-Orgle
Marcia Reinhart
Meghan Gallagher
Nicholas Summers
Oliver Sartor
P2860
P356
10.1080/03007995.2017.1341869
P407
P577
2017-06-12T00:00:00Z